Prothena Corporation Plc (PTRA): Positioning Among Top Debt-Free Stocks
Express News | Oppenheimer Maintains Outperform on Prothena Corp, Lowers Price Target to $62
Oppenheimer Maintains Prothena(PRTA.US) With Buy Rating, Cuts Target Price to $62
Express News | Prothena Corporation PLC : Oppenheimer Cuts Target Price to $62 From $66
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Prothena (PRTA) and Xenon (XENE)
Express News | Cantor Fitzgerald Reiterates Overweight on Prothena Corp
Express News | RBC Capital Maintains Sector Perform on Prothena Corp, Lowers Price Target to $24
Prothena Corp Analyst Ratings
Time To Tune In To Prothena?
Prothena (PRTA) Q2 Earnings Benefit From Collaboration Revenues
Express News | Prothena Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
Analyst Endorses Prothena's Therapeutic Advances in Parkinson's and Alzheimer's Treatments
RBC Cuts Price Target on Prothena to $24 From $28, Keeps Sector Perform, Speculative Risk
Prothena's Promising Pipeline and Strong Financials Merit a Buy Rating, With an $83 Price Target
Express News | Prothena Corporation PLC : Leerink Partners Cuts Target Price to $70 From $80
Prothena: Q2 Earnings Snapshot
Express News | Prothena Corporation Qtrly Shr $1.22
Express News | Prothena Corporation : Revised Year-End Cash Guidance to Be Approximately $468 Mln in Cash, Cash Equivalents and Restricted Cash
Express News | Prothena Corp Q2 Collaboration Revenue $132.000M
Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q2 Revenue $132M